María Jesús Santesmases – författare

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.

This book reconstructs the early circulation of penicillin in Spain, a country exhausted by civil war (1936–1939), and oppressed by Franco’s dictatorship. Embedded in the post-war recovery, penicillin’s voyages through time and across geographies – professional, political and social – were both material and symbolic. This powerful antimicrobial captivated the imagination of the general public, medical practice, science and industry, creating high expectations among patients, who at times experienced little or no effect. Penicillin’s lack of efficacy against some microbes fueled the search for new wonder drugs and sustained a decades-long research agenda built on the post-war concept of development through scientific and technological achievements. This historical reconstruction of the social life of penicillin between the 1940s and 1980s – through the dictatorship to democratic transition – explores political, public, medical, experimental and gender issues, and the rise of antibiotic resistance.